Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.8600
-0.17-16.50%
At close: -
$0.8865
0.033.08%
After Hours: Mar 21, 7:22 PM EDT
Comments
Loading...
Biofrontera Analyst Ratings and Price Targets | NASDAQ:BFRI | Benzinga
Biofrontera Inc has a consensus price target of $7 based on the ratings of 2 analysts. The high is $7 issued by Benchmark on November 15, 2024. The low is $7 issued by Benchmark on November 15, 2024. The 3 most-recent analyst ratings were released by Benchmark on November 15, 2024, August 16, 2024, and August 31, 2023, respectively. With an average price target of $10.67 between Benchmark, there's an implied 1103.23% upside for Biofrontera Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
Benchmark
1calculated from analyst ratings
Analyst Ratings for Biofrontera
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 11/15/2024 | Buy Now | 689.62% | Benchmark | Bruce Jackson42% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2024 | Buy Now | 689.62% | Benchmark | Bruce Jackson42% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 08/31/2023 | Buy Now | 1930.46% | Benchmark | Bruce Jackson42% | → $18 | Reiterates | Buy → Buy | Get Alert |
| 07/05/2023 | Buy Now | 1930.46% | Benchmark | Bruce Jackson42% | $140 → $18 | Maintains | Buy | Get Alert |
| 05/15/2023 | Buy Now | 689.62% | Benchmark | Bruce Jackson42% | → $140 | Reiterates | Buy → Buy | Get Alert |
| 03/09/2023 | Buy Now | 689.62% | Benchmark | Jackson Ader64% | → $140 | Reiterates | → Buy | Get Alert |
| 01/31/2023 | Buy Now | 689.62% | Benchmark | Bruce Jackson42% | $220 → $140 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Biofrontera (BFRI) stock?
The latest price target for Biofrontera (NASDAQ:BFRI) was reported by Benchmark on November 15, 2024. The analyst firm set a price target for $7.00 expecting BFRI to rise to within 12 months (a possible 689.62% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biofrontera (BFRI)?
The latest analyst rating for Biofrontera (NASDAQ:BFRI) was provided by Benchmark, and Biofrontera reiterated their buy rating.
When was the last upgrade for Biofrontera (BFRI)?
There is no last upgrade for Biofrontera
When was the last downgrade for Biofrontera (BFRI)?
There is no last downgrade for Biofrontera.
When is the next analyst rating going to be posted or updated for Biofrontera (BFRI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biofrontera, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biofrontera was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.
Is the Analyst Rating Biofrontera (BFRI) correct?
While ratings are subjective and will change, the latest Biofrontera (BFRI) rating was a reiterated with a price target of $7.00 to $7.00. The current price Biofrontera (BFRI) is trading at is $0.89, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.